SEC Form 4 · accession 0001144204-15-003555
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliot M Maza
Director
Period of report
Jan 21, 2015
Accepted (ET)
Jan 23, 2015 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F1 | $1.89 | Jan 21, 2015 | A | 50,000 | A | — | Jan 21, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The stock options shall vest quarterly over a three-year period, with 1/12 of the stock options granted vesting quarterly commencing on January 21, 2015.
- F2These securities were granted as compensation for the Reporting Person who was appointed as Chairman of the Audit Committee of the Board of Directors of the Issuer.